Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021)
SARS‐CoV‐2 infects human cells by binding its spike protein to the human ACE2 receptor. Using a peptide biopanning strategy, the authors have discovered small anti‐ACE2 peptides that can effectively block the SARS‐CoV‐2/ACE2 interaction. The anti‐ACE2 peptides can be potentially used as prophylactic...
Gespeichert in:
| Veröffentlicht in: | Advanced therapeutics 2021-07, Vol.4 (7), p.n/a |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 7 |
| container_start_page | |
| container_title | Advanced therapeutics |
| container_volume | 4 |
| creator | Adhikary, Pratik Kandel, Sashi Mamani, Umar‐Farouk Mustafa, Bahaa Hao, Siyuan Qiu, Jianming Fetse, John Liu, Yanli Ibrahim, Nurudeen Mohammed Li, Yongren Lin, Chien‐Yu Omoscharka, Evanthia Cheng, Kun |
| description | SARS‐CoV‐2 infects human cells by binding its spike protein to the human ACE2 receptor. Using a peptide biopanning strategy, the authors have discovered small anti‐ACE2 peptides that can effectively block the SARS‐CoV‐2/ACE2 interaction. The anti‐ACE2 peptides can be potentially used as prophylactic or therapeutic agents for SARS‐CoV‐2 and other ACE2‐mediated viruses. This is reported by Kun Cheng and co‐workers in article number 2100087. |
| doi_str_mv | 10.1002/adtp.202170016 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_adtp_202170016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ADTP202170016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1296-3c7416fce9a79f0c95038b51270b9019ef7a81252679b5d2cc4b9e153407fbf63</originalsourceid><addsrcrecordid>eNqFkLFOwzAQhi0EElXpyuwRhqZnJ47jMUoLVKpERQtr5Di2apQ2UWwVZeMReEaehERFwMZyd7q779evH6FrAgEBoDNZ-iagQAkHIPEZGtEwjqehSPj5n_kSTZx7hR4AEnLGRkjNrVP1Ubcdrg3e7GVV4fTg7ef7R5otKF7rxttSO-xrvDzsbGE93qRPm_6e1S99pf3aaOXt0foO36TlMcDbnW5lE2A-GxzdXqELIyunJ999jJ7vFtvsYbp6vF9m6WqqCBW9QcUjEhulheTCgBIMwqRghHIoBBChDZcJoYzGXBSspEpFhdCEhRFwU5g4HKPgpKva2rlWm7xp7V62XU4gH1LKh5Tyn5R6QJyAN1vp7p_vPJ1v17_sFxycawE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021)</title><source>Wiley Journals</source><creator>Adhikary, Pratik ; Kandel, Sashi ; Mamani, Umar‐Farouk ; Mustafa, Bahaa ; Hao, Siyuan ; Qiu, Jianming ; Fetse, John ; Liu, Yanli ; Ibrahim, Nurudeen Mohammed ; Li, Yongren ; Lin, Chien‐Yu ; Omoscharka, Evanthia ; Cheng, Kun</creator><creatorcontrib>Adhikary, Pratik ; Kandel, Sashi ; Mamani, Umar‐Farouk ; Mustafa, Bahaa ; Hao, Siyuan ; Qiu, Jianming ; Fetse, John ; Liu, Yanli ; Ibrahim, Nurudeen Mohammed ; Li, Yongren ; Lin, Chien‐Yu ; Omoscharka, Evanthia ; Cheng, Kun</creatorcontrib><description>SARS‐CoV‐2 infects human cells by binding its spike protein to the human ACE2 receptor. Using a peptide biopanning strategy, the authors have discovered small anti‐ACE2 peptides that can effectively block the SARS‐CoV‐2/ACE2 interaction. The anti‐ACE2 peptides can be potentially used as prophylactic or therapeutic agents for SARS‐CoV‐2 and other ACE2‐mediated viruses. This is reported by Kun Cheng and co‐workers in article number 2100087.</description><identifier>ISSN: 2366-3987</identifier><identifier>EISSN: 2366-3987</identifier><identifier>DOI: 10.1002/adtp.202170016</identifier><language>eng</language><ispartof>Advanced therapeutics, 2021-07, Vol.4 (7), p.n/a</ispartof><rights>2021 Wiley‐VCH GmbH</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadtp.202170016$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadtp.202170016$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Adhikary, Pratik</creatorcontrib><creatorcontrib>Kandel, Sashi</creatorcontrib><creatorcontrib>Mamani, Umar‐Farouk</creatorcontrib><creatorcontrib>Mustafa, Bahaa</creatorcontrib><creatorcontrib>Hao, Siyuan</creatorcontrib><creatorcontrib>Qiu, Jianming</creatorcontrib><creatorcontrib>Fetse, John</creatorcontrib><creatorcontrib>Liu, Yanli</creatorcontrib><creatorcontrib>Ibrahim, Nurudeen Mohammed</creatorcontrib><creatorcontrib>Li, Yongren</creatorcontrib><creatorcontrib>Lin, Chien‐Yu</creatorcontrib><creatorcontrib>Omoscharka, Evanthia</creatorcontrib><creatorcontrib>Cheng, Kun</creatorcontrib><title>Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021)</title><title>Advanced therapeutics</title><description>SARS‐CoV‐2 infects human cells by binding its spike protein to the human ACE2 receptor. Using a peptide biopanning strategy, the authors have discovered small anti‐ACE2 peptides that can effectively block the SARS‐CoV‐2/ACE2 interaction. The anti‐ACE2 peptides can be potentially used as prophylactic or therapeutic agents for SARS‐CoV‐2 and other ACE2‐mediated viruses. This is reported by Kun Cheng and co‐workers in article number 2100087.</description><issn>2366-3987</issn><issn>2366-3987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkLFOwzAQhi0EElXpyuwRhqZnJ47jMUoLVKpERQtr5Di2apQ2UWwVZeMReEaehERFwMZyd7q779evH6FrAgEBoDNZ-iagQAkHIPEZGtEwjqehSPj5n_kSTZx7hR4AEnLGRkjNrVP1Ubcdrg3e7GVV4fTg7ef7R5otKF7rxttSO-xrvDzsbGE93qRPm_6e1S99pf3aaOXt0foO36TlMcDbnW5lE2A-GxzdXqELIyunJ999jJ7vFtvsYbp6vF9m6WqqCBW9QcUjEhulheTCgBIMwqRghHIoBBChDZcJoYzGXBSspEpFhdCEhRFwU5g4HKPgpKva2rlWm7xp7V62XU4gH1LKh5Tyn5R6QJyAN1vp7p_vPJ1v17_sFxycawE</recordid><startdate>202107</startdate><enddate>202107</enddate><creator>Adhikary, Pratik</creator><creator>Kandel, Sashi</creator><creator>Mamani, Umar‐Farouk</creator><creator>Mustafa, Bahaa</creator><creator>Hao, Siyuan</creator><creator>Qiu, Jianming</creator><creator>Fetse, John</creator><creator>Liu, Yanli</creator><creator>Ibrahim, Nurudeen Mohammed</creator><creator>Li, Yongren</creator><creator>Lin, Chien‐Yu</creator><creator>Omoscharka, Evanthia</creator><creator>Cheng, Kun</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202107</creationdate><title>Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021)</title><author>Adhikary, Pratik ; Kandel, Sashi ; Mamani, Umar‐Farouk ; Mustafa, Bahaa ; Hao, Siyuan ; Qiu, Jianming ; Fetse, John ; Liu, Yanli ; Ibrahim, Nurudeen Mohammed ; Li, Yongren ; Lin, Chien‐Yu ; Omoscharka, Evanthia ; Cheng, Kun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1296-3c7416fce9a79f0c95038b51270b9019ef7a81252679b5d2cc4b9e153407fbf63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adhikary, Pratik</creatorcontrib><creatorcontrib>Kandel, Sashi</creatorcontrib><creatorcontrib>Mamani, Umar‐Farouk</creatorcontrib><creatorcontrib>Mustafa, Bahaa</creatorcontrib><creatorcontrib>Hao, Siyuan</creatorcontrib><creatorcontrib>Qiu, Jianming</creatorcontrib><creatorcontrib>Fetse, John</creatorcontrib><creatorcontrib>Liu, Yanli</creatorcontrib><creatorcontrib>Ibrahim, Nurudeen Mohammed</creatorcontrib><creatorcontrib>Li, Yongren</creatorcontrib><creatorcontrib>Lin, Chien‐Yu</creatorcontrib><creatorcontrib>Omoscharka, Evanthia</creatorcontrib><creatorcontrib>Cheng, Kun</creatorcontrib><collection>CrossRef</collection><jtitle>Advanced therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adhikary, Pratik</au><au>Kandel, Sashi</au><au>Mamani, Umar‐Farouk</au><au>Mustafa, Bahaa</au><au>Hao, Siyuan</au><au>Qiu, Jianming</au><au>Fetse, John</au><au>Liu, Yanli</au><au>Ibrahim, Nurudeen Mohammed</au><au>Li, Yongren</au><au>Lin, Chien‐Yu</au><au>Omoscharka, Evanthia</au><au>Cheng, Kun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021)</atitle><jtitle>Advanced therapeutics</jtitle><date>2021-07</date><risdate>2021</risdate><volume>4</volume><issue>7</issue><epage>n/a</epage><issn>2366-3987</issn><eissn>2366-3987</eissn><abstract>SARS‐CoV‐2 infects human cells by binding its spike protein to the human ACE2 receptor. Using a peptide biopanning strategy, the authors have discovered small anti‐ACE2 peptides that can effectively block the SARS‐CoV‐2/ACE2 interaction. The anti‐ACE2 peptides can be potentially used as prophylactic or therapeutic agents for SARS‐CoV‐2 and other ACE2‐mediated viruses. This is reported by Kun Cheng and co‐workers in article number 2100087.</abstract><doi>10.1002/adtp.202170016</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2366-3987 |
| ispartof | Advanced therapeutics, 2021-07, Vol.4 (7), p.n/a |
| issn | 2366-3987 2366-3987 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_adtp_202170016 |
| source | Wiley Journals |
| title | Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity (Adv. Therap. 7/2021) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A53%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20Small%20Anti%E2%80%90ACE2%20Peptides%20to%20Inhibit%20SARS%E2%80%90CoV%E2%80%902%20Infectivity%20(Adv.%20Therap.%207/2021)&rft.jtitle=Advanced%20therapeutics&rft.au=Adhikary,%20Pratik&rft.date=2021-07&rft.volume=4&rft.issue=7&rft.epage=n/a&rft.issn=2366-3987&rft.eissn=2366-3987&rft_id=info:doi/10.1002/adtp.202170016&rft_dat=%3Cwiley_cross%3EADTP202170016%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |